The formal approval a medicine must hold from a regulator, such as the MHRA in the UK, before it can lawfully be sold or supplied for a stated medical use. A peptide without UK marketing authorisation is not a licensed medicine in the UK, whatever its status may be in another country, which is why this site states each peptide’s marketing-authorisation status individually rather than assuming one status applies to the whole catalogue.
Peptides where this matters
-
TesamorelinTH9507
Not licensed in the UK. Growth-hormone-releasing hormone analogue studied for visceral fat in HIV-associated lipodystrophy, in randomised trials.
StrongNot licensed in the UK
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.